Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 25-Mar-2022 titled Sun Pharma Presents Phase 3 Data for WINLEVI�� (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting
Press Release Mar 25 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Jan 31 2022
- Sun Pharma launches PrCEQUA, the first dry eye treatment with nanomicellar technology, in Canada
- Press Release Jan 27 2022
- Sun Pharmaceutical Industries: Dividend Updates
- Press Release Jan 18 2022
Later from Sun Pharmaceutical Industries
- Press Release Mar 30 2022
- Press Release May 12 2022
- Press Release May 16 2022
- Press Release May 18 2022
- Press Release May 27 2022
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries